Bruno Clément

发表

Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study.

M. Ziol, S. Imbeaud, J. Zucman‐Rossi, 2021, The Lancet. Oncology.

Increased Lipiodol uptake in hepatocellular carcinoma possibly due to increased membrane fluidity by dexamethasone and tamoxifen.

S. Bayat, J. Raoul, F. Gaboriau, 2010, Nuclear medicine and biology.

Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients

K. Tarte, B. Fromenty, T. Hauet, 2021, International journal of molecular sciences.

Dosimetry Based on 99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with 90Y-Loaded Glass Microspheres: Preliminary Results

Y. Rolland, J. Raoul, H. Mesbah, 2012, The Journal of Nuclear Medicine.

New insights into quetiapine metabolism using molecular networking

P. Allard, P. Ferron, I. Morel, 2020, Scientific Reports.

High Prognostic Value of 18F-FDG PET for Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Long-Term Evaluation

M. Cuggia, A. Devillers, J. Raoul, 2014, The Journal of Nuclear Medicine.

Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis

K. Boudjema, Y. Rolland, A. Guillygomarc’h, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Urinary TIMP‐2 and MMP‐2 are significantly associated with poor bladder compliance in adult patients with spina bifida

F. Naudet, B. Peyronnet, C. Brochard, 2019, Neurourology and urodynamics.

Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability.

C. Coulouarn, M. Pracht, J. Edeline, 2015, Journal of vascular and interventional radiology : JVIR.

Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary Results

J. Raoul, M. Latournerie, M. Pracht, 2013, International journal of hepatology.

In vitro demonstration of synergy/additivity between (188)rhenium and sorafenib on hepatoma lines: preliminary results.

J. Raoul, M. Pracht, J. Edeline, 2013, Anticancer research.

Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?

B. Fromenty, B. Mégarbane, P. Ferron, 2020, Biochimie.

Personalized Dosimetry with Intensification Using 90Y-Loaded Glass Microsphere Radioembolization Induces Prolonged Overall Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis

K. Boudjema, Y. Rolland, J. Raoul, 2015, The Journal of Nuclear Medicine.

Volumetric Changes after 90Y Radioembolization for Hepatocellular Carcinoma in Cirrhosis: An Option to Portal Vein Embolization in a Preoperative Setting?

K. Boudjema, Y. Rolland, J. Raoul, 2013, Annals of Surgical Oncology.

Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization

Y. Rolland, J. Raoul, P. Bourguet, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Automation of labelling of Lipiodol with high-activity generator-produced 188Re.

J. Raoul, N. Lepareur, V. Ardisson, 2011, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Effectiveness of quantitative MAA SPECT/CT for the definition of vascularized hepatic volume and dosimetric approach: phantom validation and clinical preliminary results in patients with complex hepatic vascularization treated with yttrium-90-labeled microspheres

Y. Rolland, P. Bourguet, M. Pracht, 2011, Nuclear medicine communications.